company background image
ALKEM logo

Alkem Laboratories NSEI:ALKEM Stock Report

Last Price

₹5.13k

Market Cap

₹617.4b

7D

-1.3%

1Y

38.7%

Updated

19 Jul, 2024

Data

Company Financials +

Alkem Laboratories Limited

NSEI:ALKEM Stock Report

Market Cap: ₹617.4b

ALKEM Stock Overview

A pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally.

ALKEM fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance5/6
Financial Health6/6
Dividends3/6

Alkem Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Alkem Laboratories
Historical stock prices
Current Share Price₹5,133.65
52 Week High₹5,578.80
52 Week Low₹3,447.00
Beta0.40
11 Month Change-0.99%
3 Month Change11.21%
1 Year Change38.71%
33 Year Change51.23%
5 Year Change182.82%
Change since IPO271.55%

Recent News & Updates

Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Jul 13
Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Jun 13
Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Recent updates

Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Jul 13
Alkem Laboratories' (NSE:ALKEM) Dividend Will Be Reduced To ₹5.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jun 27
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Jun 13
Alkem Laboratories (NSE:ALKEM) Has Announced That Its Dividend Will Be Reduced To ₹5.00

Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Jun 01
Alkem Laboratories Limited (NSE:ALKEM) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

May 22
Earnings Tell The Story For Alkem Laboratories Limited (NSE:ALKEM)

Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Feb 13
Alkem Laboratories Limited (NSE:ALKEM) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

Jan 17
Investors Appear Satisfied With Alkem Laboratories Limited's (NSE:ALKEM) Prospects

We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Dec 27
We Think Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt With Ease

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Sep 14
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Aug 02
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Jul 07
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

May 22
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Mar 27
We Think Alkem Laboratories (NSE:ALKEM) Can Stay On Top Of Its Debt

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Dec 26
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Sep 20
These 4 Measures Indicate That Alkem Laboratories (NSE:ALKEM) Is Using Debt Reasonably Well

Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Jul 27
Alkem Laboratories' (NSE:ALKEM) Dividend Is Being Reduced To ₹4.00

Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Jul 13
Alkem Laboratories' (NSE:ALKEM) Shareholders Will Receive A Smaller Dividend Than Last Year

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Jun 11
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

May 23
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Mar 06
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Feb 21
Does Alkem Laboratories (NSE:ALKEM) Have A Healthy Balance Sheet?

Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Feb 08
Alkem Laboratories (NSE:ALKEM) Is Paying Out A Larger Dividend Than Last Year

Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Jan 09
Should You Be Adding Alkem Laboratories (NSE:ALKEM) To Your Watchlist Today?

Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Nov 30
Does This Valuation Of Alkem Laboratories Limited (NSE:ALKEM) Imply Investors Are Overpaying?

Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly

Nov 17
Here's Why Alkem Laboratories (NSE:ALKEM) Can Manage Its Debt Responsibly

I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut

Sep 07
I Built A List Of Growing Companies And Alkem Laboratories (NSE:ALKEM) Made The Cut

Here's Why Alkem Laboratories Limited's (NSE:ALKEM) CEO May Deserve A Raise

Aug 20
Here's Why Alkem Laboratories Limited's (NSE:ALKEM) CEO May Deserve A Raise

Alkem Laboratories (NSE:ALKEM) Is Increasing Its Dividend To ₹5.00

Aug 03
Alkem Laboratories (NSE:ALKEM) Is Increasing Its Dividend To ₹5.00

Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Jul 19
Is Alkem Laboratories (NSE:ALKEM) Using Too Much Debt?

Shareholder Returns

ALKEMIN PharmaceuticalsIN Market
7D-1.3%0.9%0.7%
1Y38.7%48.8%44.7%

Return vs Industry: ALKEM underperformed the Indian Pharmaceuticals industry which returned 48.8% over the past year.

Return vs Market: ALKEM underperformed the Indian Market which returned 44.7% over the past year.

Price Volatility

Is ALKEM's price volatile compared to industry and market?
ALKEM volatility
ALKEM Average Weekly Movement4.2%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.2%

Stable Share Price: ALKEM has not had significant price volatility in the past 3 months.

Volatility Over Time: ALKEM's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
197316,871Vikas Guptawww.alkemlabs.com

Alkem Laboratories Limited, a pharmaceutical company, engages in the development, manufacture, and sale of pharmaceutical and nutraceutical products in India and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, dermatology, cardiac, respiratory, gastro-intestinal, central nervous system, urology, and gynaecology, as well as vitamins, minerals, and nutrients; and pain analgesic, anti-diabetic, and neurology products. Alkem Laboratories Limited was incorporated in 1973 and is headquartered in Mumbai, India.

Alkem Laboratories Limited Fundamentals Summary

How do Alkem Laboratories's earnings and revenue compare to its market cap?
ALKEM fundamental statistics
Market cap₹617.43b
Earnings (TTM)₹17.96b
Revenue (TTM)₹126.68b

34.2x

P/E Ratio

4.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALKEM income statement (TTM)
Revenue₹126.68b
Cost of Revenue₹49.38b
Gross Profit₹77.30b
Other Expenses₹59.34b
Earnings₹17.96b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)150.19
Gross Margin61.02%
Net Profit Margin14.18%
Debt/Equity Ratio11.3%

How did ALKEM perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

27%

Payout Ratio

Does ALKEM pay a reliable dividends?

See ALKEM dividend history and benchmarks
When do you need to buy ALKEM by to receive an upcoming dividend?
Alkem Laboratories dividend dates
Ex Dividend DateAug 10 2024
Dividend Pay DateSep 29 2024
Days until Ex dividend21 days
Days until Dividend pay date71 days

Does ALKEM pay a reliable dividends?

See ALKEM dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.